Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001062993-25-004865
Filing Date
2025-03-07
Accepted
2025-03-07 11:57:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 10811
2 EXHIBIT 8 exhibit8.htm EX-8 9171
  Complete submission text file 0001062993-25-004865.txt   21671
Mailing Address 405 LEXINGTON AVENUE 58TH FLOOR NEW YORK NY 10174
Business Address 405 LEXINGTON AVENUE 58TH FLOOR NEW YORK NY 10174 212-542-4635
Saba Capital Management, L.P. (Filed by) CIK: 0001510281 (see all company filings)

EIN.: 800361690 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 333 WEST WACKER DR. CHICAGO IL 60606
Business Address 333 WEST WACKER DR. CHICAGO IL 60606 312-917-8146
Nuveen Core Plus Impact Fund (Subject) CIK: 0001835068 (see all company filings)

EIN.: 000000000 | State of Incorp.: MA
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-93505 | Film No.: 25718502